Home  »  Business   »  Takeda Pharmaceutical Company Limited (TAK) upgrad...

Takeda Pharmaceutical Company Limited (TAK) upgraded Issued by Wall Street Gurus

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Takeda Pharmaceutical Company Limited (NYSE:TAK) went up by 2.37% from its latest closing price compared to the recent 1-year high of $19.97. The company’s stock price has collected 3.26% of gains in the last five trading sessions. Press Release reported 6 hours ago that Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference

Is It Worth Investing in Takeda Pharmaceutical Company Limited (NYSE :TAK) Right Now?

Takeda Pharmaceutical Company Limited (NYSE:TAK) scored a price-to-earnings ratio above its average ratio, recording 10.98 x from its present earnings ratio. Plus, the 36-month beta value for TAK is at 0.97.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


TAK currently public float of 3.12B and currently shorts hold a 0.28% ratio of that float. Today, the average trading volume of TAK was 2.59M shares.

TAK’s Market Performance

TAK stocks went up by 3.26% for the week, with a monthly jump of 5.17% and a quarterly performance of 0.14%, while its annual performance rate touched -22.27%. The volatility ratio for the week stands at 1.96% while the volatility levels for the past 30 days are set at 1.18% for Takeda Pharmaceutical Company Limited. The simple moving average for the period of the last 20 days is 3.99% for TAK stocks with a simple moving average of -10.66% for the last 200 days.

Analysts’ Opinion of TAK

Cowen gave a rating of “Market Perform” to TAK, setting the target price at $19.50 in the report published on November 01st of the previous year.

TAK Trading at 2.86% from the 50-Day Moving Average

After a stumble in the market that brought TAK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.68% of loss for the given period.

Volatility was left at 1.18%, however, over the last 30 days, the volatility rate increased by 1.96%, as shares surge +5.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.92% upper at present.

During the last 5 trading sessions, TAK rose by +3.26%, which changed the moving average for the period of 200-days by -25.76% in comparison to the 20-day moving average, which settled at $13.73. In addition, Takeda Pharmaceutical Company Limited saw 4.48% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for TAK

Current profitability levels for the company are sitting at:

  • +14.00 for the present operating margin
  • +56.24 for the gross margin

The net margin for Takeda Pharmaceutical Company Limited stands at +11.76. The total capital return value is set at 4.38, while invested capital returns managed to touch 3.81. Equity return is now at value 9.30, with 3.80 for asset returns.

Based on Takeda Pharmaceutical Company Limited (TAK), the company’s capital structure generated 98.12 points at debt to equity in total, while total debt to capital is 49.53. Total debt to assets is 39.28, with long-term debt to equity ratio resting at 96.72. Finally, the long-term debt to capital ratio is 48.82.

>> 7 Top Picks for the Post-Pandemic Economy <<

When we switch over and look at the enterprise to sales, we see a ratio of 2.68, with the company’s debt to enterprise value settled at 0.49. The receivables turnover for the company is 4.00 and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.53.

Leave a Comment

Your email address will not be published. Required fields are marked *

Is Clean Energy Fuels Corp. (CLNE) a Keeper?

Clean Energy Fuels Corp. (NASDAQ:CLNE) went down by -0.69% from its latest closing price compared to the recent 1-year high of $19.79. The company’s stock




Download Free eBook For


100% free. stop anytime no spam